EP Patent

EP1189900B1 — Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Assigned to Bristol Myers Squibb Co · Expires 2004-01-14 · 22y expired

What this patent protects

There is provided a novel series of heterocyclic aminopyrrolidine compounds of Formula Iwherein R1, R2, R3, R4, W, Z and the wavy bond <CUSTOM-CHARACTER FILE="US06211225-20010403-P00001.TIF" ID="CUSTOM-CHARACTER-00001"> are as defined herein which bind to th…

USPTO Abstract

There is provided a novel series of heterocyclic aminopyrrolidine compounds of Formula Iwherein R1, R2, R3, R4, W, Z and the wavy bond <CUSTOM-CHARACTER FILE="US06211225-20010403-P00001.TIF" ID="CUSTOM-CHARACTER-00001"> are as defined herein which bind to the human melatonin receptor and therefore are useful as melatonergic agents.

Drugs covered by this patent

Patent Metadata

Patent number: EP1189900B1
Jurisdiction: EP
Classification: —
Expires: 2004-01-14
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.